# Covariance Labs Inc. — Form D

Covariance Labs Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2026-03-09
- Form: D
- Accession: 0001231919-26-000240
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 6
- Date of first sale: 2026-01-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-575815

## Issuer

- Name: Covariance Labs Inc.
- CIK: 0002116173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1350 AVENUE OF THE AMERICAS, SUITE 1720, NEW YORK, NY, 10019
- Phone: 9147210835

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Michael Fleder | Director | New York, NY |
| Thomas Jermoluk | Director | New York, NY |
| Michael Fleder | Executive Officer | New York, NY |

## More

- [CIK 2116173 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2116173&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-26-000240.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.